31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Read more
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025
Read more
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Read more
Making local impact using global training in liver cancer research
30 October 2025
Read more
Faster CARs: overcoming cellular exhaustion to enhance cancer immunotherapies
29 October 2025
Read more
Improving immunotherapies for lung cancer
29 October 2025
Read more